Furthermore, small-molecule bromodomain-containing protein-4 (BRD4) inhibitor displayed a potent antitumor effect on the zebrafish breast cancer model by targeting BRD4 without causing any cytotoxic effect46. Here, BRD4 is linked to breast cancer.